Treatment of Constrictive Pericarditis
Pericardiectomy is the definitive treatment for chronic permanent constrictive pericarditis 1. This surgical approach represents the mainstay of therapy and is the only curative option for established, irreversible constriction.
Treatment Algorithm Based on Disease Phenotype
The management of constrictive pericarditis fundamentally depends on distinguishing between transient/inflammatory versus chronic/permanent constriction:
For Transient or Inflammatory Constrictive Pericarditis
When active pericardial inflammation is present (evidenced by elevated CRP, pericardial enhancement on CMR, or recent onset), medical therapy should be attempted first 2:
- NSAIDs (aspirin 750-1000 mg every 8 hours OR ibuprofen 600 mg every 8 hours) with gastroprotection
- Colchicine (0.5 mg twice daily if ≥70 kg, or 0.5 mg once daily if <70 kg) for at least 3-6 months 1
- Corticosteroids (prednisone 0.2-0.5 mg/kg/day) may be added in refractory cases or when there are specific indications (autoimmune disease, contraindications to NSAIDs) 2
- IL-1 inhibitors can be considered for refractory inflammatory cases 2
This inflammatory phenotype often occurs in idiopathic, post-surgical, or autoimmune etiologies and may resolve with aggressive anti-inflammatory therapy 3, 2.
For Chronic Permanent Constrictive Pericarditis
Radical pericardiectomy is indicated when 1:
- Pericardial calcification is present on CT
- Symptoms persist despite medical therapy
- There is no evidence of active inflammation
- Chronic fibrosis has developed (typically >3 months duration)
Radical pericardiectomy is superior to partial resection in terms of functional recovery 4. The surgery should be performed at high-volume centers with expertise in pericardial disease 4.
Diagnostic Workup to Guide Treatment Decision
Before deciding on treatment approach, establish the phenotype:
CT and/or CMR are Class I indications to assess:
- Pericardial calcifications (CT) - suggests chronic, irreversible disease
- Pericardial thickness and inflammation (CMR) - active inflammation suggests potential for medical therapy 1
Cardiac catheterization is indicated when non-invasive methods don't provide definitive diagnosis 1
CRP and inflammatory markers should be measured - elevation suggests inflammatory/transient phenotype amenable to medical therapy 1
Critical Prognostic Factors
Outcomes after pericardiectomy are significantly worse in 4:
- Radiation-associated disease (consistently poor outcomes)
- Mixed constrictive-restrictive physiology (myocardial involvement)
- Advanced end-organ dysfunction (hepatic/renal impairment)
- Tuberculous etiology (higher risk but still potentially curable)
These factors should inform surgical timing and patient counseling.
Common Pitfalls
Do not use corticosteroids as first-line therapy - they are Class III (not recommended) for acute pericarditis and should only be used when NSAIDs/colchicine fail or are contraindicated 1. Corticosteroid use may actually increase recurrence rates.
Do not delay surgery in chronic constriction - waiting for "medical optimization" in established fibrotic disease only allows progression of end-organ dysfunction, worsening surgical outcomes 4.
Do not perform partial pericardiectomy - radical pericardiectomy provides superior functional recovery 4.
Special Consideration: Effusive-Constrictive Pericarditis
In effusive-constrictive pericarditis (persistent elevated right atrial pressure after pericardiocentesis), most inflammatory cases respond to anti-inflammatory treatment, while pericardiectomy is reserved for persistent, irreversible physiology despite optimal medical therapy 3. Tuberculous cases require antimicrobial therapy with corticosteroids in selected patients 3.